drugset / Trial / NCT02869425

To Assess Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With MS

NCT02869425

RandomizedParallel-groupTriple-blindOther

Summary

This study is designed to assess the effects of a therapeutic dose of arbaclofen extended release (ER) tablets compared with placebo on human sperm concentration, motility, and morphology in male subjects with multiple sclerosis (MS).

Timeline

Start
2016-07
Primary completion
2018-10
Completion
2019-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Arbaclofen Small molecule 15 mg

Indications